Stereotaxis

Stereotaxis

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases. Learn more

Launch date
Employees
Market cap
$186m
Enterprise valuation
$182m (Public information from Sep 2024)
Saint-Louis Département de Saint-Louis (HQ)
Authorizing premium user...